<div class="container">

<table style="width: 100%;"><tr>
<td>epi.sssupc</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>
Sample size for a parallel superiority trial, continuous outcome
</h2>

<h3>Description</h3>

<p>Sample size for a parallel superiority trial, continuous outcome. 
</p>


<h3>Usage</h3>

<pre><code class="language-R">epi.sssupc(treat, control, sigma, delta, n, power, r = 1, nfractional = FALSE, 
   alpha)
</code></pre>


<h3>Arguments</h3>

<table>
<tr style="vertical-align: top;">
<td><code>treat</code></td>
<td>
<p>the expected mean of the outcome of interest in the treatment group.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>control</code></td>
<td>
<p>the expected mean of the outcome of interest in the control group.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>sigma</code></td>
<td>
<p>the expected population standard deviation of the outcome of interest.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>delta</code></td>
<td>
<p>the equivalence limit, expressed as the absolute change in the outcome of interest that represents a clinically meaningful difference. For a superiority trial the value entered for <code>delta</code> must be greater than or equal to zero.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>n</code></td>
<td>
<p>scalar, the total number of study subjects in the trial.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>power</code></td>
<td>
<p>scalar, the required study power.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>r</code></td>
<td>
<p>scalar, the number in the treatment group divided by the number in the control group.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>nfractional</code></td>
<td>
<p>logical, return fractional sample size.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>alpha</code></td>
<td>
<p>scalar, defining the desired alpha level.</p>
</td>
</tr>
</table>
<h3>Value</h3>

<p>A list containing the following: 
</p>
<table>
<tr style="vertical-align: top;">
<td><code>n.total</code></td>
<td>
<p>the total number of study subjects required.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>n.treat</code></td>
<td>
<p>the required number of study subject in the treatment group.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>n.control</code></td>
<td>
<p>the required number of study subject in the control group.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>delta</code></td>
<td>
<p>the equivalence limit, as entered by the user.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>power</code></td>
<td>
<p>the specified or calculated study power.</p>
</td>
</tr>
</table>
<h3>Note</h3>

<p>Consider a clinical trial comparing two groups, a standard treatment (<code class="reqn">s</code>) and a new treatment (<code class="reqn">n</code>). In each group, the mean of the outcome of interest for subjects receiving the standard treatment is <code class="reqn">N_{s}</code> and the mean of the outcome of interest for subjects receiving the new treatment is <code class="reqn">N_{n}</code>. We specify the absolute value of the maximum acceptable difference between <code class="reqn">N_{n}</code> and <code class="reqn">N_{s}</code> as <code class="reqn">\delta</code>. For a superiority trial the value entered for <code>delta</code> must be greater than or equal to zero.
</p>
<p>For a superiority trial the null hypothesis is:
</p>
<p><code class="reqn">H_{0}: N_{s} - N_{n} = 0</code> 
</p>
<p>The alternative hypothesis is:
</p>
<p><code class="reqn">H_{1}: N_{s} - N_{n} != 0</code>
</p>
<p>When calculating the power of a study, the argument <code>n</code> refers to the total study size (that is, the number of subjects in the treatment group plus the number in the control group).
</p>
<p>For a comparison of the key features of superiority, equivalence and non-inferiority trials, refer to the documentation for <code>epi.ssequb</code>.</p>


<h3>References</h3>

<p>Chow S, Shao J, Wang H (2008). Sample Size Calculations in Clinical Research. Chapman &amp; Hall/CRC Biostatistics Series, page 61.
</p>
<p>Julious SA (2004). Sample sizes for clinical trials with normal data. Statistics in Medicine 23: 1921 - 1986.
</p>
<p>Pocock SJ (1983). Clinical Trials: A Practical Approach. Wiley, New York.
</p>
<p>Wang B, Wang H, Tu X, Feng C (2017). Comparisons of superiority, non-inferiority, and equivalence trials. Shanghai Archives of Psychiatry 29, 385 - 388. DOI: 10.11919/j.issn.1002-0829.217163.
</p>


<h3>Examples</h3>

<pre><code class="language-R">## EXAMPLE 1:
## A pharmaceutical company is interested in conducting a clinical trial
## to compare two cholesterol lowering agents for treatment of patients with
## congestive heart disease (CHD) using a parallel design. The primary 
## efficacy parameter is the concentration of high density lipoproteins
## (HDL). We consider the situation where the intended trial is to test 
## superiority of the test drug over the active control agent. Sample 
## size calculations are to be calculated to achieve 80% power at the
## 5% level of significance.

## In this example, we assume that if treatment results in a 5 unit 
## (i.e., delta = 5) increase in HDL it is declared to be superior to the
## active control. Assume the standard deviation of HDL is 10 units and 
## the HDL concentration in the treatment group is 20 units and the 
## HDL concentration in the control group is 20 units.

epi.sssupc(treat = 20, control = 20, sigma = 10, delta = 5, n = NA, 
   power = 0.80, r = 1, nfractional = FALSE, alpha = 0.05)

## A total of 100 subjects need to be enrolled in the trial, 50 in the 
## treatment group and 50 in the control group.
</code></pre>


</div>